Acuren (NYSEAMERICAN:TIC) Raised to “Hold” at Zacks Research

Acuren (NYSEAMERICAN:TICGet Free Report) was upgraded by analysts at Zacks Research to a “hold” rating in a research note issued to investors on Tuesday,Zacks.com reports.

A number of other analysts also recently commented on the company. Jefferies Financial Group restated a “buy” rating and issued a $15.00 target price on shares of Acuren in a research note on Friday, November 14th. UBS Group lowered their price objective on Acuren from $15.00 to $11.50 and set a “neutral” rating on the stock in a research report on Friday, November 14th. Baird R W raised shares of Acuren to a “hold” rating in a report on Thursday, October 9th. Finally, Robert W. Baird started coverage on shares of Acuren in a report on Thursday, October 9th. They set a “neutral” rating and a $15.00 price target on the stock. One research analyst has rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $13.83.

Read Our Latest Stock Report on Acuren

Acuren Stock Down 1.3%

NYSEAMERICAN:TIC opened at $10.17 on Tuesday. The firm’s fifty day moving average is $10.90 and its two-hundred day moving average is $11.24. Acuren has a one year low of $8.76 and a one year high of $14.94.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in TIC. HB Wealth Management LLC acquired a new stake in shares of Acuren in the second quarter worth approximately $166,000. Goldman Sachs Group Inc. purchased a new position in Acuren in the 1st quarter valued at $4,429,000. Geode Capital Management LLC acquired a new stake in Acuren during the 2nd quarter worth $25,003,000. Ameritas Investment Partners Inc. acquired a new stake in Acuren during the 2nd quarter worth $117,000. Finally, Clearline Capital LP purchased a new stake in shares of Acuren during the first quarter worth $33,254,000.

Acuren Company Profile

(Get Free Report)

Acuren Corporation provides critical asset integrity services in North America. Its activities include various nondestructive testing (NDT) solutions, such as radiography, ultrasonic testing, magnetic particle inspection, penetrant testing, and visual inspection. Its NDT activities include inspection and evaluation of industrial equipment through various technology-enabled methods to ensure asset integrity, avoid accidents, and comply with regulatory requirements without destroying the asset or component.

Featured Articles

Analyst Recommendations for Acuren (NYSEAMERICAN:TIC)

Receive News & Ratings for Acuren Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acuren and related companies with MarketBeat.com's FREE daily email newsletter.